Berlin - A so-called nationwide patient-oriented medication plan is intended to increase drug therapy safety (AMTS) in the future. The first trials in three model regions in Thuringia, Saxony and Northern Bavaria are imminent. There is also project funded by the state of Rhineland-Palatinate. They start between November 2014 and January 2015 and have term of two years. This is reported by the drug commission of the German medical profession () after meeting with representatives of the Federal Ministry of Health (), der and der, der and others.
The medication plan is an important project within the framework of the “. The BMG is funding this action plan. A coordination group at AkdÄ is responsible for implementation. "Drug therapy, especially in multimorbid patients, is often impaired by the fact that the total medication is not known at all or only insufficiently known," explained the Medicines Commission.
On the one hand, it is not possible for doctors, pharmacists and nurses to fully consider duplicate medications, side effects, interactions, contraindications, necessary dose adjustments and the like in drug therapy. On the other hand, it affects the patient's adherence to therapy if they are not reliably informed about which drugs they should take, how and when.
Some Doctor, hospital and pharmacy software manufacturers already offer medication plans. However, their contents and formats differ depending on the software manufacturer, so that not all parties involved can use them. This is where the “nationwide patient-oriented medication plan” comes into play. The coordination group in the AkdÄ has drawn up specification and agreed it with all those involved in drug therapy and the software manufacturers. In addition to the data structure, this specification also describes the layout of the medication plan. One of the model projects that is now starting is preceded by readability test, the results of which are to be incorporated into the specification of the medication plan.
“We are assuming that general practitioners will work with the medication plan first and that doctors from other specialties will increasingly be involved in the course of the project “, it said from the drug commission to the Deutsches Ärzteblatt. Depending on the project approach, the medication plan is aimed at patients who have to take at least three to five drugs continuously. The respective doctor or pharmacist is responsible for introducing the patient. For this purpose, different strategies are currently being developed in the projects.
“The progress in the development of the specification for uniform medication plan has already contributed to the fact that the drug database manufacturers standardize their information on drugs in terms of structure and content in order to ensure interoperability to ensure ”, it said from the AkdÄ.